Trulicity mechanism of action?

How Trulicity (dulaglutide) works in the body

Trulicity’s active ingredient, dulaglutide, is a GLP-1 receptor agonist. It binds to GLP-1 receptors and mimics key actions of the body’s incretin hormone GLP-1. These actions mainly include boosting glucose-dependent insulin release from the pancreas and reducing glucagon secretion, which lowers blood sugar levels. Trulicity also slows gastric emptying and can increase satiety, which tends to reduce food intake and further helps improve blood glucose control [1][2].

What happens to blood sugar after you take it

Because Trulicity’s insulin and glucagon effects are glucose-dependent, it helps lower high blood glucose while limiting the risk of pushing glucose too low compared with therapies that directly stimulate insulin regardless of glucose level. The net effect is improved fasting and post-meal glucose control [1].

Why Trulicity is taken once weekly

Trulicity is formulated so it can last longer in the body, enabling weekly dosing. Its prolonged action supports sustained GLP-1 receptor activity across the week, helping maintain glucose control between doses [1][2].

What to expect compared with other diabetes drugs (mechanism-level)

Compared with insulin, Trulicity does not replace insulin directly. Instead, it increases the body’s own insulin response when glucose is elevated and decreases glucagon, plus it slows stomach emptying. Compared with GLP-1 alternatives, the shared core mechanism is GLP-1 receptor agonism, though differences in drug design and dosing schedule affect duration and clinical use [1][2].

Common patient-relevant effects tied to the mechanism

Slower gastric emptying and increased satiety are consistent with why GLP-1 receptor agonists like Trulicity often cause gastrointestinal side effects (such as nausea), especially when starting treatment or after dose changes [2].

References

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/
[2] https://www.ema.europa.eu/en/medicines